| Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review C Grønhøj Larsen, M Gyldenløve, DH Jensen, MH Therkildsen, K Kiss, ... British journal of cancer 110 (6), 1587-1594, 2014 | 265 | 2014 |
| MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis MB Løvendorf, JR Zibert, M Gyldenløve, MA Røpke, L Skov Journal of dermatological science 75 (2), 133-139, 2014 | 115 | 2014 |
| Patients with psoriasis are insulin resistant M Gyldenløve, H Storgaard, JJ Holst, T Vilsbøll, FK Knop, L Skov Journal of the American Academy of Dermatology 72 (4), 599-605, 2015 | 108 | 2015 |
| Lack of effect of the glucagon‐like peptide‐1 receptor agonist liraglutide on psoriasis in glucose‐tolerant patients–a randomized placebo‐controlled trial A Faurschou, M Gyldenløve, U Rohde, JP Thyssen, C Zachariae, L Skov, ... Journal of the European Academy of Dermatology and Venereology 29 (3), 555-559, 2015 | 56 | 2015 |
| Increased expression of glucagon‐like peptide‐1 receptors in psoriasis plaques A Faurschou, J Pedersen, M Gyldenløve, SS Poulsen, JJ Holst, ... Experimental dermatology 22 (2), 150-152, 2013 | 41 | 2013 |
| Severe hypercalcaemia, nephrocalcinosis, and multiple paraffinomas caused by paraffin oil injections in a young bodybuilder M Gyldenløve, S Rørvig, L Skov, D Hansen The Lancet 383 (9934), 2098, 2014 | 37 | 2014 |
| Allergic rhinitis is often undiagnosed and untreated: results from a general population study of D anish adults C Grønhøj Larsen, M Gyldenløve, A Linneberg The clinical respiratory journal 7 (4), 354-358, 2013 | 28 | 2013 |
| Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis M Gyldenløve, T Vilsbøll, C Zachariae, JJ Holst, FK Knop, L Skov Journal of internal medicine 278 (6), 660-670, 2015 | 27 | 2015 |
| Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO) M Gyldenløve, H Meteran, JA Sørensen, S Fage, Y Yao, J Lindhardsen, ... The Lancet Regional Health–Europe 30, 2023 | 26 | 2023 |
| Distinguishing hyperhidrosis and normal physiological sweat production: new data and review of hyperhidrosis data for 1980–2013 L Thorlacius, M Gyldenløve, C Zachariae, BC Carlsen International journal of dermatology 54 (10), e409-e415, 2015 | 26 | 2015 |
| Determinants of fasting hyperglucagonemia in patients with type 2 diabetes and nondiabetic control subjects M Demant, JI Bagger, MP Suppli, A Lund, M Gyldenløve, KB Hansen, ... Metabolic Syndrome and Related Disorders 16 (10), 530-536, 2018 | 24 | 2018 |
| Glucose metabolism in patients with psoriasis NU Friis, N Hoffmann, M Gyldenløve, L Skov, T Vilsbøll, FK Knop, ... British Journal of Dermatology 180 (2), 264-271, 2019 | 22 | 2019 |
| Validation of psoriasis severity classification based on use of topical or systemic treatment. A Egeberg, M Gyldenløve, C Zachariae, L Skov Journal of the European Academy of Dermatology and Venereology: JEADV 32 (1 …, 2017 | 21 | 2017 |
| Psoriasis and the F ramingham risk score in a D anish hospital cohort M Gyldenløve, P Jensen, A Linneberg, JP Thyssen, C Zachariae, ... International Journal of Dermatology 53 (9), 1086-1090, 2014 | 21 | 2014 |
| Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy HC Ring, A Egeberg, C Zachariae, SF Thomsen, M Gyldenløve The British Journal of Dermatology 187 (5), 813, 2022 | 18 | 2022 |
| Eucalyptus contact allergy. M Gyldenløve, T Menné, JP Thyssen Contact Dermatitis (01051873) 71 (5), 2014 | 18 | 2014 |
| Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccine. M Gyldenløve, L Skov, CB Hansen, P Garred Journal of the European Academy of Dermatology & Venereology 35 (9), 2021 | 17 | 2021 |
| Short‐term treatment with methotrexate does not affect microvascular endothelial function in patients with psoriasis M Gyldenløve, P Jensen, MB Løvendorf, C Zachariae, PR Hansen, L Skov Journal of the European Academy of Dermatology and Venereology 29 (3), 591-594, 2015 | 17 | 2015 |
| Long‐term clearance of severe plaque psoriasis with oral roflumilast. M Gyldenløve, H Meteran, C Zachariae, A Egeberg Journal of the European Academy of Dermatology & Venereology 37 (3), 2023 | 16 | 2023 |
| Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy A Egeberg, H Meteran, M Gyldenløve, C Zachariae British Journal of Dermatology 185 (6), 1251-1252, 2021 | 16 | 2021 |
